These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 12198692)

  • 21. The V249I polymorphism of the CX3CR1 gene is associated with fibrostenotic disease behavior in patients with Crohn's disease.
    Sabate JM; Ameziane N; Lamoril J; Jouet P; Farmachidi JP; Soulé JC; Harnois F; Sobhani I; Jian R; Deybach JC; de Prost D; Coffin B
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):748-55. PubMed ID: 18617779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [NOD2 gene mutation in Moroccan patients with Crohn's disease: prevalence, genotypic study and correlation of NOD2 gene mutation with the phenotype of Crohn's disease].
    Tamzaourte M; Errabih I; Krami H; Maha F; Maria L; Benzzoubeir N; Ouazzani L; Sefiani A; Ouazzani H
    Pan Afr Med J; 2017; 27():116. PubMed ID: 28819537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pattern recognition receptor and autophagy gene variants are associated with development of antimicrobial antibodies in Crohn's disease.
    Murdoch TB; Xu W; Stempak JM; Landers C; Targan SR; Rotter JI; Silverberg MS
    Inflamm Bowel Dis; 2012 Sep; 18(9):1743-8. PubMed ID: 22275320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The c-insertion mutation of the NOD2 gene is associated with fistulizing and fibrostenotic phenotypes in Crohn's disease.
    Radlmayr M; Török HP; Martin K; Folwaczny C
    Gastroenterology; 2002 Jun; 122(7):2091-2. PubMed ID: 12055616
    [No Abstract]   [Full Text] [Related]  

  • 25. Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan.
    Bonen DK; Ogura Y; Nicolae DL; Inohara N; Saab L; Tanabe T; Chen FF; Foster SJ; Duerr RH; Brant SR; Cho JH; Nuñez G
    Gastroenterology; 2003 Jan; 124(1):140-6. PubMed ID: 12512038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NOD2/CARD15 mutations in Polish and Bosnian populations with and without Crohn's disease: prevalence and genotype-phenotype analysis.
    Salkic NN; Adler G; Zawada I; Alibegovic E; Karakiewicz B; Kozlowska-Wiechowska A; Wasilewicz M; Sulzyc-Bielicka V; Bielicki D
    Bosn J Basic Med Sci; 2015 May; 15(2):67-72. PubMed ID: 26042516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NOD2/CARD15 does not influence response to infliximab in Crohn's disease.
    Vermeire S; Louis E; Rutgeerts P; De Vos M; Van Gossum A; Belaiche J; Pescatore P; Fiasse R; Pelckmans P; Vlietinck R; Merlin F; Zouali H; Thomas G; Colombel JF; Hugot JP;
    Gastroenterology; 2002 Jul; 123(1):106-11. PubMed ID: 12105838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Crohn's disease-associated insertion polymorphism (3020insC) in the NOD2 gene is not associated with psoriasis vulgaris, palmo-plantar pustular psoriasis or guttate psoriasis.
    Young C; Allen MH; Cuthbert A; Ameen M; Veal C; Leman J; Burden AD; Kirby B; Griffiths CE; Trembath RC; Mathew CG; Barker JN
    Exp Dermatol; 2003 Aug; 12(4):506-9. PubMed ID: 12930309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of inflammatory bowel disease classification changes on NOD2 genotype-phenotype associations in a population-based cohort.
    Gearry RB; Roberts RL; Burt MJ; Frampton CM; Chapman BA; Collett JA; Shirley P; Allington MD; Kennedy MA; Barclay ML
    Inflamm Bowel Dis; 2007 Oct; 13(10):1220-7. PubMed ID: 17538984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Frequency analysis of NOD2 gene mutations in Korean patients with Crohn's disease].
    Lee GH; Kim CG; Kim JS; Jung HC; Song IS
    Korean J Gastroenterol; 2005 Mar; 45(3):162-8. PubMed ID: 15778542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a uniform, very aggressive disease phenotype in all homozygous carriers of the NOD2 mutation p.Leu1007fsX1008 with Crohn's disease and active smoking status resulting in ileal stenosis requiring surgery.
    Schnitzler F; Friedrich M; Angelberger M; Diegelmann J; Stallhofer J; Wolf C; Dütschler J; Truniger S; Olszak T; Beigel F; Tillack C; Lohse P; Brand S
    PLoS One; 2020; 15(7):e0236421. PubMed ID: 32716958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variants at the 3p21 locus influence susceptibility and phenotype both in adults and early-onset patients with inflammatory bowel disease.
    Latiano A; Palmieri O; Corritore G; Valvano MR; Bossa F; Cucchiara S; Castro M; Riegler G; De Venuto D; D'Incà R; Andriulli A; Annese V
    Inflamm Bowel Dis; 2010 Jul; 16(7):1108-17. PubMed ID: 20024904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study.
    Hampe J; Grebe J; Nikolaus S; Solberg C; Croucher PJ; Mascheretti S; Jahnsen J; Moum B; Klump B; Krawczak M; Mirza MM; Foelsch UR; Vatn M; Schreiber S
    Lancet; 2002 May; 359(9318):1661-5. PubMed ID: 12020527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn's disease: phenotype-genotype correlations.
    Lakatos PL; Lakatos L; Szalay F; Willheim-Polli C; Osterreicher C; Tulassay Z; Molnar T; Reinisch W; Papp J; Mozsik G; Ferenci P;
    World J Gastroenterol; 2005 Mar; 11(10):1489-95. PubMed ID: 15770725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NOD2 mutations are associated with the development of intestinal failure in the absence of Crohn's disease.
    Schäffler H; Schneider N; Hsieh CJ; Reiner J; Nadalin S; Witte M; Königsrainer A; Blumenstock G; Lamprecht G
    Clin Nutr; 2013 Dec; 32(6):1029-35. PubMed ID: 23562557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NOD2/CARD15 Mutations among Bedouin Arabs with Inflammatory Bowel Disease: Frequency and Phenotype Correlation.
    Abu Freha N; Badarna W; Abu Tailakh M; Abu Kaf H; Fich A; Schwartz D; Segal A; Elkrinawi J; Karban A
    Isr Med Assoc J; 2018 Nov; 20(11):695-699. PubMed ID: 30430799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of NOD2 with Crohn's disease in a homogenous Irish population.
    Bairead E; Harmon DL; Curtis AM; Kelly Y; O'Leary C; Gardner M; Leahy DT; Vaughan P; Keegan D; O'Morain C; O'Donoghue D; Shanahan F; Parfrey NA; Quane KA
    Eur J Hum Genet; 2003 Mar; 11(3):237-44. PubMed ID: 12673278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Associations of NOD2 polymorphisms with Erysipelotrichaceae in stool of in healthy first degree relatives of Crohn's disease subjects.
    Turpin W; Bedrani L; Espin-Garcia O; Xu W; Silverberg MS; Smith MI; Garay JAR; Lee SH; Guttman DS; Griffiths A; Moayyedi P; Panaccione R; Huynh H; Steinhart HA; Aumais G; Dieleman LA; Turner D; ; Paterson AD; Croitoru K
    BMC Med Genet; 2020 Oct; 21(1):204. PubMed ID: 33059653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibodies to saccharomyces cerevisiae in Crohn's disease: higher titers are associated with a greater frequency of mutant NOD2/CARD15 alleles and with a higher probability of complicated disease.
    Dassopoulos T; Frangakis C; Cruz-Correa M; Talor MV; Burek CL; Datta L; Nouvet F; Bayless TM; Brant SR
    Inflamm Bowel Dis; 2007 Feb; 13(2):143-51. PubMed ID: 17206688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases.
    Frank DN; Robertson CE; Hamm CM; Kpadeh Z; Zhang T; Chen H; Zhu W; Sartor RB; Boedeker EC; Harpaz N; Pace NR; Li E
    Inflamm Bowel Dis; 2011 Jan; 17(1):179-84. PubMed ID: 20839241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.